vs
Genie Energy Ltd.（GNE）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
Genie Energy Ltd.的季度营收约是再鼎医药的1.1倍（$138.3M vs $127.1M），Genie Energy Ltd.同比增速更快（23.6% vs 17.1%），过去两年再鼎医药的营收复合增速更高（20.8% vs 14.8%）
Genie Energy Ltd.是一家总部位于美国新泽西州纽瓦克的能源企业，作为控股公司，旗下业务涵盖零售能源、国际零售能源、能源服务以及油气业务，迈克尔·斯坦因现任该公司首席执行官。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
GNE vs ZLAB — 直观对比
营收规模更大
GNE
是对方的1.1倍
$127.1M
营收增速更快
GNE
高出6.5%
17.1%
两年增速更快
ZLAB
近两年复合增速
14.8%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $138.3M | $127.1M |
| 净利润 | $6.7M | — |
| 毛利率 | 21.7% | 51.0% |
| 营业利润率 | 5.0% | -54.6% |
| 净利率 | 4.9% | — |
| 营收同比 | 23.6% | 17.1% |
| 净利润同比 | -33.9% | — |
| 每股收益（稀释后） | $0.26 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GNEZLAB
| Q4 25 | — | $127.1M | ||
| Q3 25 | $138.3M | $115.4M | ||
| Q2 25 | $105.3M | $109.1M | ||
| Q1 25 | $136.8M | $105.7M | ||
| Q4 24 | $102.9M | $108.5M | ||
| Q3 24 | $111.9M | $101.8M | ||
| Q2 24 | $90.7M | $100.1M | ||
| Q1 24 | $119.7M | $87.1M |
净利润GNEZLAB
| Q4 25 | — | — | ||
| Q3 25 | $6.7M | $-36.0M | ||
| Q2 25 | $2.8M | $-40.7M | ||
| Q1 25 | $10.3M | $-48.4M | ||
| Q4 24 | $-15.3M | — | ||
| Q3 24 | $10.2M | $-41.7M | ||
| Q2 24 | $9.6M | $-80.3M | ||
| Q1 24 | $8.1M | $-53.5M |
毛利率GNEZLAB
| Q4 25 | — | 51.0% | ||
| Q3 25 | 21.7% | 59.5% | ||
| Q2 25 | 22.3% | 60.6% | ||
| Q1 25 | 27.3% | 63.6% | ||
| Q4 24 | 32.5% | 61.5% | ||
| Q3 24 | 33.9% | 64.1% | ||
| Q2 24 | 36.8% | 64.9% | ||
| Q1 24 | 28.2% | 61.4% |
营业利润率GNEZLAB
| Q4 25 | — | -54.6% | ||
| Q3 25 | 5.0% | -42.3% | ||
| Q2 25 | 1.9% | -50.3% | ||
| Q1 25 | 9.4% | -53.3% | ||
| Q4 24 | -20.2% | -62.6% | ||
| Q3 24 | 10.4% | -66.6% | ||
| Q2 24 | 11.6% | -76.0% | ||
| Q1 24 | 8.2% | -80.7% |
净利率GNEZLAB
| Q4 25 | — | — | ||
| Q3 25 | 4.9% | -31.2% | ||
| Q2 25 | 2.7% | -37.3% | ||
| Q1 25 | 7.5% | -45.8% | ||
| Q4 24 | -14.9% | — | ||
| Q3 24 | 9.1% | -40.9% | ||
| Q2 24 | 10.6% | -80.2% | ||
| Q1 24 | 6.8% | -61.4% |
每股收益（稀释后）GNEZLAB
| Q4 25 | — | $-0.05 | ||
| Q3 25 | $0.26 | $-0.03 | ||
| Q2 25 | $0.11 | $-0.04 | ||
| Q1 25 | $0.40 | $-0.04 | ||
| Q4 24 | $-0.58 | $-0.09 | ||
| Q3 24 | $0.38 | $-0.04 | ||
| Q2 24 | $0.36 | $-0.08 | ||
| Q1 24 | $0.30 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $109.8M | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $198.8M | $715.5M |
| 总资产 | $394.1M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GNEZLAB
| Q4 25 | — | $689.6M | ||
| Q3 25 | $109.8M | $717.2M | ||
| Q2 25 | $106.0M | $732.2M | ||
| Q1 25 | $118.3M | $757.3M | ||
| Q4 24 | $110.1M | $779.7M | ||
| Q3 24 | $141.8M | $616.1M | ||
| Q2 24 | $126.8M | $630.0M | ||
| Q1 24 | $106.9M | $650.8M |
股东权益GNEZLAB
| Q4 25 | — | $715.5M | ||
| Q3 25 | $198.8M | $759.9M | ||
| Q2 25 | $197.0M | $791.7M | ||
| Q1 25 | $198.0M | $810.8M | ||
| Q4 24 | $190.5M | $840.9M | ||
| Q3 24 | $211.1M | $667.7M | ||
| Q2 24 | $202.1M | $704.2M | ||
| Q1 24 | $192.9M | $762.2M |
总资产GNEZLAB
| Q4 25 | — | $1.2B | ||
| Q3 25 | $394.1M | $1.2B | ||
| Q2 25 | $383.1M | $1.2B | ||
| Q1 25 | $384.4M | $1.2B | ||
| Q4 24 | $371.3M | $1.2B | ||
| Q3 24 | $341.7M | $985.3M | ||
| Q2 24 | $322.8M | $987.4M | ||
| Q1 24 | $328.3M | $988.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.9M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-26.7M |
| 自由现金流率自由现金流/营收 | — | -21.0% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | 2.07× | — |
| 过去12个月自由现金流最近4个季度 | — | $-158.9M |
8季度趋势，按日历期对齐
经营现金流GNEZLAB
| Q4 25 | — | $-26.0M | ||
| Q3 25 | $13.9M | $-32.0M | ||
| Q2 25 | $1.1M | $-31.0M | ||
| Q1 25 | $15.3M | $-61.7M | ||
| Q4 24 | $13.0M | $-55.8M | ||
| Q3 24 | $24.4M | $-26.8M | ||
| Q2 24 | $20.4M | $-42.2M | ||
| Q1 24 | $12.9M | $-90.1M |
自由现金流GNEZLAB
| Q4 25 | — | $-26.7M | ||
| Q3 25 | — | $-35.0M | ||
| Q2 25 | — | $-33.9M | ||
| Q1 25 | $13.6M | $-63.2M | ||
| Q4 24 | — | $-58.4M | ||
| Q3 24 | $21.9M | $-28.2M | ||
| Q2 24 | $20.1M | $-42.9M | ||
| Q1 24 | $11.7M | $-91.1M |
自由现金流率GNEZLAB
| Q4 25 | — | -21.0% | ||
| Q3 25 | — | -30.4% | ||
| Q2 25 | — | -31.1% | ||
| Q1 25 | 9.9% | -59.9% | ||
| Q4 24 | — | -53.8% | ||
| Q3 24 | 19.6% | -27.7% | ||
| Q2 24 | 22.1% | -42.9% | ||
| Q1 24 | 9.8% | -104.5% |
资本支出强度GNEZLAB
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | 1.3% | 1.5% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | 2.2% | 1.3% | ||
| Q2 24 | 0.4% | 0.7% | ||
| Q1 24 | 1.0% | 1.1% |
现金转化率GNEZLAB
| Q4 25 | — | — | ||
| Q3 25 | 2.07× | — | ||
| Q2 25 | 0.40× | — | ||
| Q1 25 | 1.49× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.39× | — | ||
| Q2 24 | 2.12× | — | ||
| Q1 24 | 1.59× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GNE
| Sales Channel Directly To Consumer | $108.8M | 79% |
| Sales Channel Through Intermediary | $23.5M | 17% |
| Genie Renewables GREW | $6.0M | 4% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
